ArticleNature communications2025
Regrafting submillimeter-scale ferromagnetic soft continuums.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Submillimeter-scale ferromagnetic soft continuums (FSCs) own innate skills in performing desirable and delicate bending for confined space navigation, especially in biological lumens. However, such tiny structures are difficult to endow with complex designs, thereby challenging to realize more sophisticated functions for various purposes, especially in vivo therapies and manipulations. Inspired by grafting for muscles and plants, we propose submillimeter-scale FSCs that can actively divide into pieces at any region, and conversely, the pieces can actively graft to each other to form the original structure or novel shapes. We define these functions as regrafting, comprising self-division and self-mergence. Implementing regrafting implies actively switching between two opposing characteristics: sufficient continuum structural strength for steering loads and a low fracture strength for division and mergence. Therefore, we developed ferromagnetic thermoplastic soft materials to replace the widely applied thermoset materials for continuums and shed the commonly required coating layers. Being made of the ferromagnetic material family that can undergo reversible elastomer-fluid transitions, the proposed FSCs can perform arbitrary division-mergence and navigate confined spaces for multiple endoscopic tasks in one go. Endowed with enhanced flexibility and reconfigurability in situ by regrafting, the proposed FSCs may open a multifunctional path for operating a wider range of biomedical tasks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.